Ground Fluor Pharmaceuticals Overview

  • Founded
  • 2012
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 5
Employees
  • Latest Deal Type
  • M&A

Ground Fluor Pharmaceuticals General Information

Description

Developer of proprietary chemical technologies designed to enhance fluorine synthesis. The company's proprietary chemical technologies develop synthesis of pharmaceutical compounds, such as Fluorine F-18 Agents for positron emitting tomography (PET) imaging, that can be produced rapidly and more reliably than current methods, enabling clients to produce flourine in much higher yields, with much higher potency.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Drug Discovery
Parent Company
Primary Office
  • 2124 Y Street
  • Flat 101
  • Lincoln, NE 68503
  • United States
+1 (402) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Ground Fluor Pharmaceuticals Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 09-Jun-2016 Completed Generating Revenue
3. Early Stage VC 17-Apr-2014 Completed Startup
2. Grant 03-Apr-2014 $726K Completed Startup
1. Grant 14-Jun-2012 $150K Completed Startup
To view Ground Fluor Pharmaceuticals’s complete valuation and funding history, request access »

Ground Fluor Pharmaceuticals Executive Team (1)

Name Title Board Seat Contact Info
Allan Green MD President, Chief Executive Officer & Founding Member
To view Ground Fluor Pharmaceuticals’s complete executive team members history, request access »

Ground Fluor Pharmaceuticals Board Members (1)

Name Representing Role Since
Stephen DiMagno Ph.D Ground Fluor Pharmaceuticals Founder, Board Member & Chair of the Scientific Advisory Board 000 0000
To view Ground Fluor Pharmaceuticals’s complete board members history, request access »

Ground Fluor Pharmaceuticals Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ground Fluor Pharmaceuticals Former Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Cedarville Investments Venture Capital Minority 000 0000 000000 0
National Science Foundation Government 000 0000 000000 0
To view Ground Fluor Pharmaceuticals’s complete investors history, request access »